GM food regulatory terms debated
Article Abstract:
Japan has been chosen as the head of a working group that would provide risk analysis and risk assessment for genetically modified foods.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Biotechnology venture capital booms in Japan
Article Abstract:
A boom in the biotechnology venture industry is taking place in Japan. Institutional investors and venture capitalists are beginning to focus their energies on biotechnology.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Drug bill cuts force firms overseas
Article Abstract:
Japan's Ministry of Health and Welfare has imposed a 9.7% cut in National Health Insurance (NHI) drug prices. The government hopes to save about Y200 billion (US$1.5 billion) in medical expenses in the current fiscal year through this move, which will be the status quo until the adoption of a reference pricing system in 2000. While the reference pricing system will address the gap between the NHI reimbursement tariff and wholesale drug prices, the specifics of the plan will not be delineated until 1999. The current price cuts are mostly aimed at products whose daily reimbursement price greatly surpasses that of competing products.
Comment:
Japan: Ministry of Health and Welfare has imposed a 9.7% cut in National Health Insurance (NHI) drug prices
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Technology's avenues, applications and acronyms for the new year. The year 2000 problem
- Abstracts: Taming the monster: companies are turning to captives to contain escalating costs for employee benefit plans. Big business sues to reclaim Y2K fix-it costs
- Abstracts: The impact of systems approaches on biological problems in drug discovery. Quorex Pharmaceuticals
- Abstracts: Low-end digital cameras: what's selling and why. CVS photo division puts customers first. Kids go digital
- Abstracts: US trends may lead to inflation surprise. Divorced from the dollar. The real threat to Wall Street